If you are outside of a covered SNF stay, Medicare may revert to Part B regulations
For Research Use Only Not intended for human consumption or therapeutic use
mobile IV hydration therapy market reached approximately $568.5 million in 2024 and is projected to expand at a 10.4% CAGR through 2030
Fever, vomiting, and reduced appetite deplete fluids and nutrients rapidly, and a compromised digestive system absorbs oral supplements poorly
In neuronal senescence model studies, the active ingredient of the product can cross the blood-brain barrier (and act directly on neurons in vitro), increase NAD+ levels in nerve cells, protect mitochondrial function, reduce neuronal apoptosis, and promote the synthesis and release of neurotransmitters (such as dopamine and acetylcholine), thereby improving signal transduction in nerve cells